PAPER Pattanayak RD, Jena R, Tripathi M, Khandelwal SK
SEARCH RESULTS
329963 RESULTS
PAPER Vann A
Listen more carefully to Alzheimer's caregivers.
J Am Geriatr Soc. 2012 Oct;60(10):2000. PubMed: 23057467PAPER Kakuda N, Akazawa K, Hatsuta H, Murayama S, Ihara Y,
Suspected limited efficacy of γ-secretase modulators.
Neurobiol Aging. 2012 Oct 8; PubMed: 23058852PAPER Tweedie D, Rachmany L, Rubovitch V, Lehrmann E, Zhang Y, Becker KG, Perez E, Miller J, Hoffer BJ, Greig NH, Pick CG
Exendin-4, a glucagon-like peptide-1 receptor agonist prevents mTBI-induced changes in hippocampus gene expression and memory deficits in mice.
Exp Neurol. 2013 Jan;239:170-82. Epub 2012 Oct 8 PubMed: 23059457PAPER Atkins ER, Bulsara MK, Panegyres PK
The natural history of early-onset dementia: the Artemis Project.
BMJ Open. 2012;2(5) PubMed: 23059847PAPER Cimini A, Gentile R, Angelucci F, Benedetti E, Pitari G, Giordano A, Ippoliti R
Neuroprotective effects of PrxI over-expression in an in vitro human Alzheimer's disease model.
J Cell Biochem. 2012 Oct 11; PubMed: 23060010PAPER Ntelios D, Berninger B, Tzimagiorgis G
Numb and Alzheimer's disease: the current picture.
Front Neurosci. 2012;6:145. PubMed: 23060745PAPER Singh B, Sharma B, Jaggi AS, Singh N
Attenuating effect of lisinopril and telmisartan in intracerebroventricular streptozotocin induced experimental dementia of Alzheimer's disease type: possible involvement of PPAR-γ agonistic property.
J Renin Angiotensin Aldosterone Syst. 2012 Oct 11; PubMed: 23060470PAPER Lu Y
Integrating experimentation and quantitative modeling to enhance discovery of Beta amyloid lowering therapeutics for Alzheimer's disease.
Front Pharmacol. 2012;3:177. PubMed: 23060797PAPER Friedland RP, Shah JJ, Farrer LA, Vardarajan B, Rebolledo-Mendez JD, Mok K, Hardy J
Behavioral variant frontotemporal lobar degeneration with amyotrophic lateral sclerosis with a chromosome 9p21 hexanucleotide repeat.
Front Neurol. 2012;3:136. PubMed: 23060854PAPER Li X, Lv Y, Yu S, Zhao H, Yao L
The effect of cadmium on Aβ levels in APP/PS1 transgenic mice.
Exp Ther Med. 2012 Jul;4(1):125-130. PubMed: 23060935PAPER Lykou E, Rankin KP, Chatziantoniou L, Boulas C, Papatriantafyllou O, Tsaousis I, Neuhaus J, Karageorgiou C, Miller BL, Papatriantafyllou JD
Big 5 Personality Changes in Greek bvFTD, AD, and MCI Patients.
Alzheimer Dis Assoc Disord. 2012 Oct 10; PubMed: 23060360PAPER Youmans KL, Tai LM, Nwabuisi-Heath E, Jungbauer L, Kanekiyo T, Gan M, Kim J, Eimer WA, Estus S, Rebeck GW, Weeber EJ, Bu G, Yu C, LaDu MJ
APOE4-specific Changes in Aβ Accumulation in a New Transgenic Mouse Model of Alzheimer Disease.
J Biol Chem. 2012 Dec 7;287(50):41774-86. PubMed: 23060451PAPER Proft J, Weiss N
A protective mutation against Alzheimer disease?
Commun Integr Biol. 2012 Jul 1;5(4):301-3. PubMed: 23060947PAPER Tsuboi Y
Environmental-genetic interactions in the pathogenesis of Parkinson's disease.
Exp Neurobiol. 2012 Sep;21(3):123-8. PubMed: 23055790Current Filters
No filters selected